Cardiac Conduction System Pacing: A Comprehensive Update.
His bundle pacing
cardiac resynchronization therapy
clinical trials
conduction system pacing
left bundle branch pacing
Journal
JACC. Clinical electrophysiology
ISSN: 2405-5018
Titre abrégé: JACC Clin Electrophysiol
Pays: United States
ID NLM: 101656995
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
received:
04
04
2023
revised:
10
05
2023
accepted:
02
06
2023
medline:
1
12
2023
pubmed:
17
8
2023
entrez:
17
8
2023
Statut:
ppublish
Résumé
The field of cardiac pacing has changed rapidly in the last several years. Since the initial description of His bundle pacing targeting the conduction system, recent advances in pacing the left bundle branch and its fascicles have evolved. The field and investigators' knowledge of conduction system pacing including relevant anatomy and physiology has advanced significantly. The aim of this review is to provide a comprehensive update on recent advances in conduction system pacing.
Identifiants
pubmed: 37589646
pii: S2405-500X(23)00391-2
doi: 10.1016/j.jacep.2023.06.005
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2358-2387Informations de copyright
Copyright © 2023 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Funding Support and Author Disclosures Work on anatomy was made possible by support from National Institutes of Health grants OT2OD023848 (to Dr K Shivkumar) and from the Tawara-McAlpine Festschrift (a component of the UCLA Amara-Yad Project). Dr Vijayaraman has received honoraria, consulting fees, and research and fellowship support from Medtronic; honoraria from Biotronik and Boston Scientific; and consulting fees from Abbott; and holds a patent for an HBP delivery tool. Dr Chelu has received research support from PCORI, National Institutes of Health, Abbott, and Impulse Dynamics; and honoraria from Impulse Dynamics. Dr Curila has received consulting fees and honoraria from Medtronic, Biotronik, and Abbott; has filed U.S. patent: US11,517,243B2: “Method of electrocardiographic signal processing and apparatus for performing the method”; and is a shareholder of VDI Technologies. Dr Dandamudi has received honoraria and consulting fees from Medtronic; and served on advisory boards of Medtronic, Biotronik, and Abbott. Dr Herweg has served as a speaker and consultant for Abbott; and has received speaking fees and fellowship support from Medtronic. Dr Jastrzebski has received honoraria and consulting fees from Medtronic and Abbott. Dr Sharma has received honoraria from Medtronic; and consulting fees from Medtronic, Abbott, Biotronik, and Boston Scientific. Dr Shivkumar is a cofounder of NeuCures Inc. Dr Tung has received honoraria and consulting fees from– Abbott. Dr Upadhyay has received honoraria from and served on advisory boards for Abbott, Biotronik, Boston Scientific, Medtronic, Philips BioTel, and Zoll Medical. Dr Vernooy has received consulting fees from Biosense Webster, Philips, Medtronic, and Abbott; honoraria from Microport; and research and educational grants (paid to institution) from Philips, Abbott, Medtronic, and Biosense Webster. Dr Whinnett has received honoraria from Medtronic and Boston Scientific; and consulting fees from Medtronic and Abbott. Dr Zanon has received honoraria from Abbott, Biotronik, Boston Scientific, Medtronic, and Microport. Dr Ellenbogen has received consulting fees from Medtronic, Boston Scientific, Abbott, and Biotronik; and honoraria from Medtronic, Boston Scientific, and Biotronik. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.